Tidal Investments LLC lessened its holdings in InterCure Ltd. (NASDAQ:INCR – Free Report) by 50.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 229,500 shares of the company’s stock after selling 230,272 shares during the period. Tidal Investments LLC owned approximately 0.50% of InterCure worth $461,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in INCR. AdvisorShares Investments LLC acquired a new position in InterCure in the second quarter worth $218,000. Renaissance Technologies LLC lifted its position in InterCure by 30.9% during the 2nd quarter. Renaissance Technologies LLC now owns 45,300 shares of the company’s stock worth $91,000 after buying an additional 10,700 shares in the last quarter. Jane Street Group LLC bought a new stake in InterCure during the 3rd quarter worth about $49,000. Finally, Virtu Financial LLC acquired a new stake in InterCure in the 3rd quarter valued at about $43,000. Institutional investors own 8.34% of the company’s stock.
InterCure Price Performance
Shares of INCR stock opened at $1.79 on Tuesday. InterCure Ltd. has a 1 year low of $1.17 and a 1 year high of $3.72. The company has a current ratio of 1.78, a quick ratio of 1.15 and a debt-to-equity ratio of 0.15. The firm’s 50 day moving average is $1.51 and its 200-day moving average is $1.89.
About InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.
Recommended Stories
- Five stocks we like better than InterCure
- Energy and Oil Stocks Explained
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Stock Market Sectors: What Are They and How Many Are There?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- Health Care Stocks Explained: Why You Might Want to Invest
- Market Overreaction: 2 Stocks to Buy on the Way Down
Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCR – Free Report).
Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.